Marshall Wace North America L.P. - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 82 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2018$7,166,000
+18.3%
1,165,250
+105.6%
0.02%
-26.5%
Q2 2018$6,058,000
-34.1%
566,709
-33.9%
0.03%
-26.1%
Q1 2018$9,193,000
+508.8%
856,763
+297.3%
0.05%
+475.0%
Q4 2017$1,510,000
-22.2%
215,6500.0%0.01%
-33.3%
Q3 2017$1,941,000
-1.5%
215,650
-1.5%
0.01%
-14.3%
Q2 2017$1,971,000
+14.6%
218,960
+1.9%
0.01%0.0%
Q1 2017$1,720,000214,9500.01%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q1 2018
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders